IgGenix Inc.
South San Francisco, US · 7 known investors
IgGenix is a clinical-stage biotechnology company focused on antibody discovery and development for allergies and immunological diseases. The company uses its proprietary SEQ SIFTER™ platform to develop first-in-class therapeutic antibodies targeting allergic cascades.
AI & Machine LearningBiotechHealthtech
Founders & leadership
KN
Kari NadeauScientific Co-Founder
Investors · 7
Competitors · 4
by search overlapBioworld10 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
argenx10 shared keywordsargenx is an immunology company that operates an antibody innovation ecosystem where scientists and antibody engineers develop novel targets, disease pathways, and therapeutic antibodies. It builds a proprietary portfolio of first-in-class product candidates, engineered with academic partners, to translate immunology research into medicines for patients.
Phigenix9 shared keywordsPhigenix develops personalized medicine for cancer, including companion diagnostics and targeted therapies for prostate and breast cancer patients. Its work centers on early detection and targeted inhibition of PAX2 and EN2 oncogenes and a cancer vaccine using Human Beta Defensin-1 (DEFB1) mRNA to direct the immune system against cancer cells.
Origene7 shared keywordsOriGene supplies research reagents including primary antibodies for flow cytometry, transfection kits (EZ-LNP and ProteanFect), RNAi gene silencing tools, and control solutions for life science laboratories. Its products serve researchers in molecular and cell biology.
Companies competing with IgGenix Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does IgGenix Inc. do?
- IgGenix is a clinical-stage biotechnology company focused on antibody discovery and development for allergies and immunological diseases. The company uses its proprietary SEQ SIFTER™ platform to develop first-in-class therapeutic antibodies targeting allergic cascades.
- Who founded IgGenix Inc.?
- IgGenix Inc. was founded by Kari Nadeau.
- Who are IgGenix Inc.'s investors?
- IgGenix Inc.'s investors include Khosla Ventures, Allerfund Ventures, Llc, FemHealth Ventures, Global Brain, Medical Incubator Japan K.K., ShangBay Capital LLC, SBI Investment.
- Where is IgGenix Inc. headquartered?
- IgGenix Inc. is headquartered in South San Francisco, US.